Pharmacokinetic and pharmacodynamic evaluation of ibrutinib for the treatment of chronic lymphocytic leukemia: rationale for lower doses

Por Bose, Prithviraj, Gandhi, Varsha V., Keating, Michael J.
Publicado no Expert Opin Drug Metab Toxicol (2016)

Pathways and mechanisms of venetoclax resistance

Por Bose, Prithviraj, Gandhi, Varsha V., Konopleva, Marina Y.
Publicado no Leuk Lymphoma (2017)

Treatment of Core Binding Factor Acute Myelogenous Leukemia with Fludarabine, Cytarabine and Granulocyte Colony Stimulating Factor Results in Improved Event-Free Survival

Por Borthakur, Gautam, Kantarjian, Hagop, Wang, Xuemei, Plunkett, William K., Gandhi, Varsha V, Faderl, Stefan, Garcia-Manero, Guillermo, Ravandi, Farhad, Pierce, Sherry, Estey, Elihu H.
Publicado em 2008

Combination of Cladribine and Cytarabine is Effective for Childhood Acute Myeloid Leukemia: Results of the St. Jude AML97 Trial

Por Rubnitz, Jeffrey E., Crews, Kristine R., Pounds, Stanley, Yang, Shengping, Campana, Dario, Gandhi, Varsha V., Raimondi, Susana C., Downing, James R., Razzouk, Bassem I., Pui, Ching-Hon, Ribeiro, Raul C.
Publicado em 2009